← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
424B5424B5Aug 8, 2023424B5424B5Dec 19, 2022424B5424B5Dec 14, 2022424B5424B5Jun 15, 2021424B5424B5Jan 22, 2021424B5424B5Nov 10, 2020424B5424B5Nov 10, 2020424B5424B5May 18, 2020424B5424B5Mar 2, 2020424B5424B5Jan 21, 2020424B5PROSPECTUS SUPPLEMENTDec 31, 2018424B5PROSPECTUS SUPPLEMENTApr 13, 2018424B5PRELIMINARY PROSPECTUS SUPPLEMENTApr 11, 2018424B5424B5Dec 29, 2017424B5424B5Mar 26, 2015424B5424B5Mar 24, 2015424B5FORM 424B5Jun 4, 2014424B5424B5Sep 24, 2013424B5424B5Sep 24, 2013424B5424B5Jul 9, 2013424B5PRELIMINARY PROSPECTUS SUPPLEMENTOct 23, 2012
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance